These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37525188)

  • 21. Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study.
    Yildirim Arslan S; Avcu G; Sahbudak Bal Z; Arslan A; Ozkinay FF; Kurugol Z
    Eur J Pediatr; 2023 Oct; 182(10):4565-4571. PubMed ID: 37526704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross-Protection Activity against Multiple SARS-CoV-2 Sublineages.
    Zhang X; Wu S; Liu J; Chen R; Zhang Y; Lin Y; Xi Z; Deng J; Pu Z; Liang C; Feng J; Li R; Lin K; Zhou M; Liu Y; Zhang X; Liu B; Zhang Y; He X; Zhang H
    Adv Sci (Weinh); 2023 Sep; 10(27):e2301034. PubMed ID: 37526323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19.
    Navitha Reddy G; Jogvanshi A; Naikwadi S; Sonti R
    Expert Rev Anti Infect Ther; 2023; 21(9):943-955. PubMed ID: 37525997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequencing the SARS-CoV-2 Genome from Stool Samples of Post-acute Cases Implicates a Novel Mutation Associated with Reduced Antibody Neutralization.
    Panova N; Allan NP; Rubas NC; Lee RH; Kunihiro BP; Umeda L; Peres R; Juarez R; Maunakea AK
    Eur J Biomed Res; 2023; 2(3):17-23. PubMed ID: 37525697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2.
    Yang L; Wang Z; Wang L; Vrancken B; Wang R; Wei Y; Rader B; Wu CH; Chen Y; Wu P; Li B; Lin Q; Dong L; Cui Y; Shi M; Brownstein JS; Stenseth NC; Yang R; Tian H
    Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2305403120. PubMed ID: 37549270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project.
    Lange B; Jaeger VK; Harries M; Rücker V; Streeck H; Blaschke S; Petersmann A; Toepfner N; Nauck M; Hassenstein MJ; Dreier M; von Holt I; Budde A; Bartz A; Ortmann J; Kurosinski MA; Berner R; Borsche M; Brandhorst G; Brinkmann M; Budde K; Deckena M; Engels G; Fenzlaff M; Härtel C; Hovardovska O; Katalinic A; Kehl K; Kohls M; Krüger S; Lieb W; Meyer-Schlinkmann KM; Pischon T; Rosenkranz D; Rübsamen N; Rupp J; Schäfer C; Schattschneider M; Schlegtendal A; Schlinkert S; Schmidbauer L; Schulze-Wundling K; Störk S; Tiemann C; Völzke H; Winter T; Klein C; Liese J; Brinkmann F; Ottensmeyer PF; Reese JP; Heuschmann P; Karch A
    Infection; 2024 Feb; 52(1):139-153. PubMed ID: 37530919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world performance of SARS-CoV-2 rapid antigen testing through the Alpha-, Delta- and Omicron-dominant waves of the COVID-19 pandemic.
    Domnich A; Orsi A; Ricucci V; De Pace V; Massaro E; Ogliastro M; Bruzzone B; Icardi G
    Int J Infect Dis; 2023 Oct; 135():18-20. PubMed ID: 37536389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive metrics for an evolving pandemic: A dynamic approach to area-level COVID-19 risk designations.
    Bilinski AM; Salomon JA; Hatfield LA
    Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2302528120. PubMed ID: 37527346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of SARS-CoV-2 Hyperimmune Immunoglobulins Following Infection Plus Vaccination vs Infection.
    Bellusci L; Golding H; Khurana S
    JAMA Netw Open; 2023 Aug; 6(8):e2327307. PubMed ID: 37540517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rethinking Immunological Risk: A Retrospective Cohort Study of Severe SARS-Cov-2 Infections in Individuals With Congenital Immunodeficiencies.
    Nguyen AA; Habiballah SB; LaBere B; Day-Lewis M; Elkins M; Al-Musa A; Chu A; Jones J; Fried AJ; McDonald D; Hoytema van Konijnenburg DP; Rockowitz S; Sliz P; Oettgen HC; Schneider LC; MacGinnitie A; Bartnikas LM; Platt CD; Ohsumi TK; Chou J
    J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3391-3399.e3. PubMed ID: 37544429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.
    Harthaller T; Falkensammer B; Bante D; Huber M; Schmitt M; Benainouna H; Rössler A; Fleischer V; von Laer D; Kimpel J; Würzner R; Borena W
    Front Immunol; 2023; 14():1196988. PubMed ID: 37545492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of host receptors for viral entry and beyond: a perspective from the spike of SARS-CoV-2.
    Xia X
    Front Microbiol; 2023; 14():1188249. PubMed ID: 37560522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of different variants of SARS-CoV-2 RNA (genome) on inanimate surfaces in high-touch public environmental surfaces.
    Noorimotlagh Z; Mirzaee SA; Seif F; Kalantar M; Roghani T; Mousavi SA; Honarmandpour A
    Sci Rep; 2023 Aug; 13(1):13058. PubMed ID: 37567996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of New-onset Type 1 Diabetes in Danish Children and Adolescents After SARS-CoV-2 Infection: A Nationwide, Matched Cohort Study.
    Bering L; Christensen AV; Birk NM; Thygesen LC; Bundgaard H; Benfield T; Nygaard U; Johannesen J; Nielsen SD; Berg SK
    Pediatr Infect Dis J; 2023 Nov; 42(11):999-1001. PubMed ID: 37566892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Observational Prospective Cohort Study of Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection of an Aerosolized, Inhaled Adenovirus Type 5-Vectored Coronavirus Disease 2019 Vaccine Given as a Second Booster Dose in Guangzhou City, China.
    Wang FZ; Zhang CH; Tang L; Rodewald LE; Wang W; Liu SY; Wang WJ; Wu D; Liu QQ; Wang XQ; Huang LF; Huang AD; Bao LM; Zhang ZB; Yin ZD
    J Infect Dis; 2024 Jan; 229(1):117-121. PubMed ID: 37565805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of genomic surveillance of SARS-CoV-2 in cats during reverse zoonosis events: potential viral evolution may occur.
    Barroso-Arévalo S; Díaz-Frutos M; Domínguez L; Sánchez-Vizcaíno JM
    Microbiol Spectr; 2023 Aug; 11(5):e0068023. PubMed ID: 37565759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.
    Mak WA; Visser W; van der Vliet M; Markus HY; Koeleman JGM; Ong DSY
    J Med Virol; 2023 Aug; 95(8):e28989. PubMed ID: 37565645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rare case of IgG4-associated disease caused by COVID-19: Case report and literature review.
    Xu YG; Zheng Y; Qiu YY
    Int J Rheum Dis; 2024 Jan; 27(1):e14863. PubMed ID: 37564026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 (novel SARS-CoV-2) neurological illness.
    Younger DS
    Handb Clin Neurol; 2023; 195():159-179. PubMed ID: 37562868
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.